KLTR vs VRTX · rev $178.7M vs P/E 30, rev $12.00B
Kaltura Inc (KLTR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Kaltura Inc (KLTR) is a software - application company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported KLTR revenue for 2024-12-31 was $178.7M. Net income was -$31.3M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. KLTR currently screens at market cap $305.7M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
KLTR currently screens at market cap $305.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the KLTR and VRTX stock pages for the full models.
Not investment advice.